PGT-M (Preimplantation Genetic Testing for Monogenic Disorders) is an advanced genetic test performed during the in vitro fertilization (IVF) process, aiming to detect specific hereditary (monogenic) diseases in the embryo.

This method allows for the identification of embryos that do not carry specific genetic diseases, thereby enabling couples to significantly reduce the risk of transmitting the disease to future generations.

PGT-M is particularly recommended:

• When one or both partners have a hereditary genetic disease
• In cases of genetic pathologies in the family history
• For the prevention of genetic risks
• For selecting a healthy embryo during the IVF process

The testing process involves taking a sample of embryonic cells (biopsy) and their genetic analysis, based on which healthy embryos are selected.

PGT-M represents a significant step forward in modern medicine, allowing for the prevention of a number of serious genetic diseases and increasing the chances of a healthy pregnancy.

Beta Plus Clinic offers professional support and complete confidentiality.